Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI Tool Predicts Markers of Alzheimer’s Disease

By HospiMedica International staff writers
Posted on 14 Aug 2025

Alzheimer’s disease is linked to the buildup of sticky proteins like amyloid beta and tau in the brain, but current detection methods often require expensive scans or specialized tests. More...

While some blood tests can detect signs of the disease, they cannot pinpoint the exact brain regions affected. Researchers have now developed an artificial intelligence (AI) solution that uses widely available and less costly tests to predict the presence and location of these proteins.

This AI tool, developed by scientists at Boston University Chobanian & Avedisian School of Medicine (Boston, MA, USA), uses brain scans, memory assessments, genetic information, health records, and medical history to detect Alzheimer’s biomarkers. The model was trained on data from seven research cohorts totaling 12,185 participants, learning to identify patterns linked to protein buildup. It was also designed to operate effectively even when some patient data was missing.

The team tested the AI on an independent group of participants not included in the training phase. The results, published in Nature Communications, show that the tool could accurately identify individuals with high amyloid or tau levels. According to the study, this AI tool could streamline patient selection for clinical trials and new drug treatments, enabling faster and more affordable diagnoses.

Additionally, by identifying disease earlier, it could support personalized intervention plans, such as targeted diets or exercise programs to slow disease progression. Researchers believe it may one day be applied to related conditions like frontotemporal dementia and chronic traumatic encephalopathy.

“The tool can help doctors quickly pick people for treatment with new drugs or to participate in research studies, thus saving time and money while reaching more patients who might not have access to costly and complicated tests,” said Vijaya B. Kolachalama, PhD, FAHA, associate professor of medicine and computer science, Boston University. “For the public, this means faster diagnoses, fewer unnecessary exams, and hope for treatments that slow the disease, improving daily life for those affected and their loved ones.”

Related Links:
Chobanian & Avedisian School of Medicine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.